Victoria de la Huerga is vice president, Investor Relations and ADM Ventures, for Archer Daniels Midland Company. In her Investor Relations role, she oversees the relationships and communications with existing and potential shareholders on ADM’s strategy and performance. In her Ventures role, she oversees ADM’s efforts to drive organic growth through internal product development, external partnerships, and investments. Prior to her current position, de la Huerga was global head of marketing and strategy for ADM’s WILD Flavors and Specialty Ingredients business unit. She has also served as head of North American beverage; head of Latin America & strategic planning; and head of North American technology and innovation for WILD Flavors. Before joining ADM, de la Huerga spent 12 years in global product development at PepsiCo where she was responsible for PepsiCo’s carbonated beverage portfolio. She also spent two years with Joseph E. Seagram & Son. De la Huerga holds a bachelor’s degree in Biochemistry from the University of Wisconsin – Madison. She has also completed executive business programs at Harvard Business School and IMD. De la Huerga serves as a Co-Chair for The American Cancer Society’s Taste of Hope event for both the 2018 and 2019 event. Prior to this, she served on the Council for Taste of Hope in 2016 and 2017. In 2019, the Illinois Diversity Council recognized ADM’s Victoria de la Huerga among the organization’s annual “Power 50” at the Illinois Women’s Conference in Chicago. The Power 50 recognizes women in leadership roles in the state of Illinois.

Isabelle set up ID Capital in 2012 when moving to Singapore after a 20-year corporate career in the luxury industry, her last position being SVP Marketing & Communications for the Cognac brand Hennessy. After looking at several emerging sectors to invest in she realized the FoodTech & AgriTech sectors were bound for dramatic change. Future Food Asia was born mid 2016 out of the belief that challenges facing agriculture are often region-specific, and thus, the best minds to tackle these problems can be found within local teams. It aims at fostering innovation in food sustainability and multiplying investment opportunities across Asia Pacific. Today Future Food Asia is in its third year and ID Capital is has been appointed as a co-investment partner in agrifoodtech startups by SEEDS Capital, the investment arm of Enterprise Singapore. Along with her team, Isabelle scouts and reviews a few hundred agrifoodtech startups every year.

Dr. Ralph is currently Director, Food and Nutrition, Biomedical Research Council (BMRC) of the Agency for Science, Technology and Research (A*STAR), Singapore. In his current position with A*STAR, Ralph is working with strategic partners to administer and develop new initiatives and programmes in the research areas of food and nutrition. He has a co-appointment as Adjunct Associate Professor with Nanyang Technological University, School of Chemical & Biomedical Engineering. He also sits on the advisory panel of the Food Innovation & Resource Centre, Singapore Polytechnic as well as multiple grant review committees.
Ralph has over 12 years of experience in the local and global biomedical and nutrition industry. He was previously Research Operations Manager for Abbott Nutrition in Asia, establishing the R&D infrastructure and managing the research portfolio for Asia.
Prior to joining Abbott Nutrition, Ralph was Research Director for ES Cell International, the first organization to provide clinical grade embryonic stem cell lines to the world’s research community (now a subsidiary of Bio Time Inc).
Ralph graduated with a master in Biology from the Johannes Gutenberg University, Mainz, Germany and attained his PhD from the National University Singapore through the Institute of Molecular and Cell Biology.

Gerard served as the Director of Partnerships, Transfer and Innovation at INRA, Europe’s top agricultural research institute. During his time at INRA he co-created, the first agro-biotech accelerator that became Enterome, a start-up pioneering the metagenomics of the digestive tract and its applications in human health. Upon retiring from INRA in 2016 he has been leveraging his domain experience to assess innovative projects and mentor teams.
Prior to INRA, he worked in various designations for the National Research Institute of Science and Technology for Environment and Agriculture (IRSTEA), and ultimately as the Director for Development and Innovation. He also held the positon of Managing Director for the Biology Division of Groupe Generale de Sante, the 1st French group of private hospitals and clinics. Between 1982 and 1992 he held many operational positions in the domain of biotechnologies applied to diagnostics and treatment, and plasma protein fractionation.
A trained engineer, Gérard graduated in 1973 from Ecole Polytechnique in France.